Treace Medical Concepts, Inc.
TMCI
$7.47
-$0.23-2.99%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 22.77% | 3.21% | -12.55% | -29.09% | -50.66% |
| Total Depreciation and Amortization | 22.94% | 36.56% | 52.91% | 65.58% | 102.00% |
| Total Amortization of Deferred Charges | 62.53% | 62.53% | 62.86% | 167.45% | 168.69% |
| Total Other Non-Cash Items | 31.92% | 55.74% | 85.30% | 87.51% | 108.26% |
| Change in Net Operating Assets | -337.83% | -5,457.93% | -161.04% | 29.13% | 77.17% |
| Cash from Operations | 50.49% | -4.94% | -7.50% | 19.86% | 21.69% |
| Capital Expenditure | -24.92% | 19.40% | -1.18% | 6.71% | 17.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -61.27% | 11.09% | 194.24% | 140.18% | 137.20% |
| Cash from Investing | -88.73% | 911.33% | 143.51% | 124.59% | 122.26% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.34% | -93.73% | -99.65% | -99.55% | -92.93% |
| Repurchase of Common Stock | -78.40% | 93.42% | 95.77% | 96.04% | 96.04% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | 64.22% | -95.22% | -99.85% | -99.73% | -99.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -264.81% | 119.91% | 74.86% | 105.95% | 106.87% |